Silverback Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $328k | 41k | 8.04 |
| 2025-12-31 | $394k | 34k | 11.66 |
| 2025-09-30 | $340k | 34k | 10.06 |
| 2025-06-30 | $478k | 27k | 17.45 |
| 2025-03-31 | $274k | 22k | 12.59 |
| 2024-12-31 | $211k | 20k | 10.59 |
| 2024-09-30 | $6.7M | 463k | 14.50 |
| 2024-06-30 | $134k | 16k | 8.52 |
| 2023-06-30 | $111k | 17k | 6.71 |
| 2023-03-31 | $76k | 12k | 6.55 |
| 2022-03-31 | $1.1M | 301k | 3.51 |
| 2021-12-31 | $2.0M | 300k | 6.66 |